

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 16)
You can purchase shares of Champions Oncology (NASDAQ:CSBR) through any online brokerage.
Other companies in Champions Oncology’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Champions Oncology has a consensus price target of $12.00.
The stock price for Champions Oncology (NASDAQ: CSBR) is $5 last updated October 7, 2026 at 7:56 AM EDT.
There are no upcoming dividends for Champions Oncology.
Champions Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Champions Oncology.
Champions Oncology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which...